Year in Review: PharmAust (ASX:PAA) with general manager, Fiona Milner
Link copied to
Stockhead’s Year in Review video series is a yearly wrap up address from company leaders showcasing latest achievements, discoveries and developments of emerging ASX companies.
In this instalment Fiona Milner, general manager at PharmAust (ASX:PAA) takes a look back on the company’s achievements in 2022.
PharmAust Limited is a clinical-stage company developing therapeutics for the treatment of different types of cancers in both humans and animals, viral and neurological diseases. The company specialise in repurposing marketed drugs, lowering the risks and costs of development.
To hear about the company’s 2022 highlights, click above.